Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Am J Drug Alcohol Abuse. 2020 Aug 27;46(6):761–768. doi: 10.1080/00952990.2020.1797064

Table 1.

Baseline demographic and clinical characteristics by treatment group (N=334).

XR-NTX (N=164) BUP-NX (N=170)
Measure N % or M (SD) N % or M (SD)
Received first dose (% yes) 132 80.5% 158 92.9%
Demographic Characteristics
Gender (% male) 109 66.5% 115 67.6%
Age 164 32.8 (8.5) 170 33.0 (9.0)
Marital status (% never married) 109 66.5% 114 67.1%
Employment (% unemployed) 105 64.0% 110 64.7%
Clinical Characteristics
IV Use (% yes) 111 67.7% 111 65.3%
Primary Opioid
 Buprenorphine 4 2.5% 1 0.6%
 Opioid analgesics 26 16.0% 32 18.9%
 Methadone 3 1.8% 4 2.4%
 Heroin 130 79.8% 132 78.1%
Primary opioid cost ($/day) 163 92.7 (70.3) 169 104.7 (84.0)
Age at onset of opioid use 164 20.6 (6.5) 170 21.2 (7.1)
Duration of opioid use (years) 164 12.2 (8.0) 170 11.7 (8.1)
First treatment episode (% yes) 59 36.0% 70 41.2%
Stimulant use (% yes)a 80 48.8% 93 54.7%
Sedative use (% yes)a 41 25.0% 53 31.2%
Heavy alcohol use (% yes)a 38 23.2% 42 24.7%
Cannabis use (% yes)a 73 44.5% 78 45.9%
Clinical
HAM-Db Score (Range: 0–52) 164 8.1 (6.1) 170 8.8 (6.5)
Any psych disorder (% yes) 113 68.9% 116 68.2%
SOWSc (Range: 0–64) 164 16.0 (12.9) 170 15.7 (13.2)
a

30-days prior to admission for detox

b

Hamilton Depression Rating Scale

c

Subjective Opiate Withdrawal Scal